Industry Collaboration within DDLS Research School

Current Collaboration Partners

From Matchmaking to Collaboration

Interested Companies

Pitch: Sprint Bioscience is a company focusing on small-molecule drug discovery in oncology. We are using our fragment-based drug design (FBDD) platform to develop drug discovery programs with a focus on first-in-class targets. The biology focus of our programs typically lies within the fields of tumor microenvironment, tumor immunity, or synthetic lethality. We are looking for postdoc/PhD candidates and collaborators that can strengthen and complement our in-house capabilities to start and drive our programs, e.g. target identification, compound design, patient stratification etc.

Contact: Martin Andersson, CSO, martin.andersson@sprintbioscience.com
Lisa Bast, Senior Scientist in Tumor Biology & Therapeutics, lisa.bast@sprintbioscience.com

Pitch: ANYO Labs is a drug discovery company developing iScore, an AI platform that screens billions of compounds in hours to identify high-potential drug candidates with a proven 25% hit rate across diverse targets. Our strength lies in delivering rapid, cost-effective hit lists and optimized leads, validated in commercial projects and public benchmarks such as CACHE 6. We are actively seeking academic collaborations for joint discovery programs as well as data integration projects—sharing your experimental datasets to refine our models and accelerate both your research and our platform development.

Contact: Marek Szczygiel, CEO, marek.szczygiel@anyolabs.com

Pitch: Navinci is a Swedish biotech company specializing in developing innovative solutions for studying protein interactions. Our mission is to advance scientific discovery by providing cutting‑edge technologies in spatial proteomics. Through this postdoctoral fellowship, we aim to identify a candidate who can help deepen and expand the applications of our technology within spatial biology, particularly through quantitative data analysis and AI‑driven methods.

Contact: Hao Xu, Head of Data, CEO, hao.xu@navinci.se

Pitch: Metasafe, founded in 2013, specializes in biotransformation and HRMS-based metabolite analysis for pharmaceutical clients. Building on this expertise, the company has launched chemical exposure analysis services, including adductomics, and is interested in DDLS for potential collaborations in omics data processing, cohort studies for exposure monitoring, and biomarker discovery.

Contact: Hitesh Motwani, Study Director, hitesh.motwani@metasafe.se

For questions please contact: ddls-rs@scilifelab.se

Last updated: 2026-02-23

Content Responsible: Johan Inganni(johan.inganni@scilifelab.se)